Hyperfine (HYPR) Competitors $1.08 -0.07 (-6.09%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$1.09 +0.01 (+1.02%) As of 07/25/2025 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HYPR vs. NYXH, DRTS, STIM, ZIMV, SMTI, BWAY, TCMD, CV, CVRX, and MGRMShould you be buying Hyperfine stock or one of its competitors? The main competitors of Hyperfine include Nyxoah (NYXH), Alpha Tau Medical (DRTS), Neuronetics (STIM), ZimVie (ZIMV), Sanara MedTech (SMTI), Brainsway (BWAY), Tactile Systems Technology (TCMD), CapsoVision (CV), CVRx (CVRX), and Monogram Orthopaedics (MGRM). These companies are all part of the "medical equipment" industry. Hyperfine vs. Its Competitors Nyxoah Alpha Tau Medical Neuronetics ZimVie Sanara MedTech Brainsway Tactile Systems Technology CapsoVision CVRx Monogram Orthopaedics Nyxoah (NASDAQ:NYXH) and Hyperfine (NASDAQ:HYPR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations and dividends. Do institutionals and insiders believe in NYXH or HYPR? 15.0% of Hyperfine shares are held by institutional investors. 17.1% of Nyxoah shares are held by insiders. Comparatively, 31.0% of Hyperfine shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts prefer NYXH or HYPR? Nyxoah currently has a consensus price target of $14.50, indicating a potential upside of 91.29%. Hyperfine has a consensus price target of $1.06, indicating a potential downside of 1.85%. Given Nyxoah's stronger consensus rating and higher possible upside, equities research analysts plainly believe Nyxoah is more favorable than Hyperfine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nyxoah 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Hyperfine 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has higher earnings & valuation, NYXH or HYPR? Hyperfine has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Hyperfine, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNyxoah$4.89M52.80-$64.10M-$2.13-3.56Hyperfine$12.89M6.52-$40.72M-$0.54-2.00 Is NYXH or HYPR more profitable? Hyperfine has a net margin of -343.42% compared to Nyxoah's net margin of -1,571.39%. Nyxoah's return on equity of -63.37% beat Hyperfine's return on equity.Company Net Margins Return on Equity Return on Assets Nyxoah-1,571.39% -63.37% -46.67% Hyperfine -343.42%-74.19%-62.40% Which has more risk & volatility, NYXH or HYPR? Nyxoah has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500. Comparatively, Hyperfine has a beta of 1.01, meaning that its stock price is 1% more volatile than the S&P 500. Does the media refer more to NYXH or HYPR? In the previous week, Hyperfine had 2 more articles in the media than Nyxoah. MarketBeat recorded 3 mentions for Hyperfine and 1 mentions for Nyxoah. Nyxoah's average media sentiment score of 1.87 beat Hyperfine's score of 0.97 indicating that Nyxoah is being referred to more favorably in the media. Company Overall Sentiment Nyxoah Very Positive Hyperfine Positive SummaryNyxoah and Hyperfine tied by winning 8 of the 16 factors compared between the two stocks. Get Hyperfine News Delivered to You Automatically Sign up to receive the latest news and ratings for HYPR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HYPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HYPR vs. The Competition Export to ExcelMetricHyperfineMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$89.51M$6.85B$5.70B$9.50BDividend YieldN/A1.27%4.60%4.01%P/E Ratio-2.0025.4528.1020.05Price / Sales6.5264.09429.3789.38Price / CashN/A20.5536.2258.56Price / Book1.614.758.665.87Net Income-$40.72M$176.14M$3.25B$258.55M7 Day Performance17.38%2.92%4.22%3.73%1 Month Performance47.70%3.23%10.51%11.75%1 Year Performance-6.90%7.28%34.40%18.03% Hyperfine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HYPRHyperfine1.4288 of 5 stars$1.08-6.1%$1.06-1.9%-6.1%$89.51M$12.89M-2.00190News CoveragePositive NewsGap UpNYXHNyxoah2.523 of 5 stars$7.94-3.4%$14.50+82.6%-10.6%$279.98M$4.89M-3.73110Positive NewsDRTSAlpha Tau Medical2.8448 of 5 stars$2.98-2.0%$8.00+168.5%+44.0%$257.85MN/A-6.4880STIMNeuronetics1.4932 of 5 stars$3.88+6.0%$5.50+41.8%+137.6%$241.98M$74.89M-2.96180Positive NewsZIMVZimVie0.5308 of 5 stars$18.76+122.3%$16.33-12.9%-13.8%$235.03M$449.75M-26.421,770News CoverageAnalyst UpgradeHigh Trading VolumeSMTISanara MedTech2.0107 of 5 stars$26.28-0.1%$49.50+88.4%-20.7%$233.84M$86.67M-19.6160Positive NewsBWAYBrainsway2.7702 of 5 stars$12.09flat$14.25+17.9%+53.3%$228.47M$41.02M60.45120Positive NewsTCMDTactile Systems Technology3.6431 of 5 stars$9.66+1.5%$16.00+65.6%-18.3%$221.32M$292.98M14.641,037Positive NewsCVCapsoVisionN/A$4.45-2.2%N/AN/A$210.87MN/A0.0090Negative NewsGap DownCVRXCVRx3.0268 of 5 stars$8.29+3.6%$14.50+74.9%-12.5%$208.58M$51.29M-3.80160Positive NewsMGRMMonogram Orthopaedics1.0841 of 5 stars$5.69+0.4%$5.40-5.1%+126.3%$202.35M$370K-12.6428Gap Up Related Companies and Tools Related Companies Nyxoah Alternatives Alpha Tau Medical Alternatives Neuronetics Alternatives ZimVie Alternatives Sanara MedTech Alternatives Brainsway Alternatives Tactile Systems Technology Alternatives CapsoVision Alternatives CVRx Alternatives Monogram Orthopaedics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HYPR) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hyperfine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hyperfine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HYPR Stock Alerts